The association between serum uric acid and survival outcomes in patients with metastatic renal cell carcinoma treated with targeted therapy
Our study highlights a noteworthy association between high SUA levels and adverse survival outcomes in patients with RCC treated with targeted therapies.
Authors
- Hüseyin Salih Semiz (ORCID: https://orcid.org/0000-0002-7083-8517)
- Faruk Recep Özalp (ORCID: https://orcid.org/0000-0002-2863-3243)
- Canberk Sencan
- Oktay Halit Aktepe (ORCID: https://orcid.org/0000-0003-3540-0701)
- Mustafa Erman (ORCID: https://orcid.org/0000-0001-5884-4669)
- Şuayib Yalçın (ORCID: https://orcid.org/0000-0001-7850-6798)
- Ahmet Melih Arslan (ORCID: https://orcid.org/0000-0002-6126-4611)
- Eda Çalışkan Yıldırım (ORCID: https://orcid.org/0000-0003-0785-0238)
- Mehmet Cihan İcli̇ (ORCID: https://orcid.org/0000-0002-7857-6902)
- Aziz Karaoğlu (ORCID: https://orcid.org/0000-0001-5500-156X)
- Mehmet Sinan Akarca
- Hatice Altas
Institutions
- Dokuz Eylül University (TR)
- Hacettepe University Hospital (TR)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1186/s12885-025-14962-8
- Citations
- 1
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 1.43